Delivery Order SPE2DB25D3022-SPE2DB25FWCFF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $30,739.23 under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $3,111.66 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on July 21, 2025, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a small-value pharmaceutical supply transaction. The award was placed of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $18,279.31 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract without set-aside designation represents a single delivery order under AmerisourceBergen's larger federal pharmaceutical supply framework. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $6,223.32 for RINVOQ ER 30 mg tablets (30-count units) under a firm fixed price contract type. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (quantity: 30-day supply) valued at $6,072.95 under a firm fixed price, non-set-aside contract. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,772.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical inventory supporting military healthcare operations. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,713.81 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit dose), effective August 4, 2025, with completion by August 5, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical supply transaction under the company's broader contract vehicle with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,223.30. This non-competitive delivery order is scheduled for ultimate completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $25,342.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $11,410.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a pediatric delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made competitively and is...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCFFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,359.12 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare systems globally. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders reflects its established position as a major pharmaceutical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 8/12/25 |